Table 1.
Demographic data, clinical presentation, and laboratory results.
Frequency | Percentage | |
---|---|---|
(N = 32 Patients) | ||
Sex | ||
Female | 27 | 84.4% |
Male | 5 | 15.6% |
Age (years, median) | 36 (range 20–65 years) | |
Age at clinical onset (years, median) | 27 (range 13–58 years) | |
Clinical presentation | ||
Cerebral syndrome | 17 | 53.1% |
Myelitis | 15 | 46.9% |
Optic neuritis | 9 | 28.1% |
Brainstem syndrome | 2 | 6.3% |
Cerebellar syndrome | 1 | 3.1% |
Disease course subtype | ||
Relapsing remitting MS | 28 | 87.5% |
Primary progressive MS | 2 | 6.25% |
Secondary progressive MS | 2 | 6.25% |
Progressive relapsing MS | 0 | 0% |
CSF oligoclonal band | ||
Not available | 16 | 50% |
Available | 16 | 50% |
Positive | 8 | 50% of all available results |
Negative | 8 | 50% of all available results |